,Set,NGenes,Direction,PValue,FDR
1,WP_SPINAL_CORD_INJURY,65,Down,1.78762661738256e-07,0.000146942907948846
2,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,2.83862347725702e-06,0.00116667424915263
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,1.19997423888252e-05,0.00328792941453809
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,27,Down,4.26585104213505e-05,0.00876632389158752
5,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,7.41467820041662e-05,0.0121897309614849
6,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,35,Down,0.000174505091247378,0.0239071975008908
7,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.000251365758764479,0.0250542058343046
8,WP_PROSTAGLANDIN_SIGNALING,21,Down,0.000274113733842982,0.0250542058343046
9,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.000290199208544472,0.0250542058343046
10,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.000311155242250595,0.0250542058343046
11,WP_IL26_SIGNALING,31,Down,0.000335275260556388,0.0250542058343046
12,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.000403494763575899,0.0276393913049491
13,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,11,Down,0.00103833985008768,0.0656550274440056
14,WP_MEVALONATE_PATHWAY,7,Down,0.00166258373468303,0.0976174164221035
15,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,40,Down,0.00210489424991351,0.11534820489526
16,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,18,Down,0.00227241787377241,0.115601628772334
17,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.00240521428131205,0.115601628772334
18,WP_HYPERTROPHY_MODEL,13,Down,0.0026494914485801,0.115601628772334
19,WP_NEUROINFLAMMATION,10,Down,0.00267569776207903,0.115601628772334
20,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0028126916976237,0.115601628772334
21,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.00391627632709899,0.153294244803589
22,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,0.00430619692811875,0.160895176132437
23,WP_GASTRIN_SIGNALING,92,Down,0.0048924106255412,0.170353427444441
24,WP_COMPLEMENT_ACTIVATION,12,Up,0.00526247396310349,0.170353427444441
25,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Down,0.00537089790696735,0.170353427444441
26,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.0056116924850275,0.170353427444441
27,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.00563667224515072,0.170353427444441
28,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.00595925536793785,0.170353427444441
29,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Down,0.00629472876199072,0.170353427444441
30,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.00631288504304655,0.170353427444441
31,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.00642452098634754,0.170353427444441
32,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,7,Up,0.00675387838071004,0.173490250904489
33,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0112022012863217,0.270717115019497
34,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0114236872441559,0.270717115019497
35,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.0115268844594676,0.270717115019497
36,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.012299684535432,0.274376508341204
37,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0124488261114488,0.274376508341204
38,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.0126840721617588,0.274376508341204
39,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0138576025926563,0.280268893682083
40,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.0139391605201307,0.280268893682083
41,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Down,0.0139793487116367,0.280268893682083
42,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.0143954266552017,0.281739064537519
43,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.015020400656093,0.287134170681592
44,WP_KETOGENESIS_AND_KETOLYSIS,7,Up,0.0156000504781576,0.291437306660125
45,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,76,Down,0.0173411319320805,0.316764676626003
46,WP_TRIACYLGLYCERIDE_SYNTHESIS,17,Up,0.0177842473949702,0.317796768666642
47,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.0199364747504475,0.333211865391501
48,WP_SEROTONIN_AND_ANXIETY,6,Down,0.0205369603643301,0.333211865391501
49,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.0209233278400877,0.333211865391501
50,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0209251405538852,0.333211865391501
51,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0210575858381108,0.333211865391501
52,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,51,Down,0.0210790961074915,0.333211865391501
53,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Down,0.0218507946670045,0.33333792096133
54,WP_BURN_WOUND_HEALING,60,Down,0.0218981115959998,0.33333792096133
55,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.022877146046078,0.341909346361383
56,WP_PEPTIDE_GPCRS,11,Down,0.0233519634735997,0.342773463844624
57,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.0239069545526388,0.34476344986437
58,WP_AGERAGE_PATHWAY,54,Down,0.0264899135018986,0.373238455308444
59,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.0272550120840821,0.373238455308444
60,WP_SYNAPTIC_VESICLE_PATHWAY,20,Down,0.0281611578033813,0.373238455308444
61,WP_IL1_SIGNALING,53,Down,0.0286420667392303,0.373238455308444
62,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0288219034932356,0.373238455308444
63,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0289049863751766,0.373238455308444
64,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.0290599283938448,0.373238455308444
65,WP_IRINOTECAN_PATHWAY,5,Up,0.0313593733886623,0.382427902537
66,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.0316305595279951,0.382427902537
67,WP_CHOLESTEROL_METABOLISM,50,Down,0.0319619151656796,0.382427902537
68,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.0320003630339306,0.382427902537
69,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.0321016122567555,0.382427902537
70,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.0327355600773966,0.384409005480286
71,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.0344408510005734,0.398737739753118
72,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.0350657491694614,0.400333969684684
73,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.0363095704859513,0.404561656448679
74,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Down,0.0364203924296864,0.404561656448679
75,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.0378282465722501,0.414597582431861
76,WP_CCL18_SIGNALING,20,Down,0.0390400321146317,0.420077580347345
77,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Down,0.0400255208305024,0.420077580347345
78,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,35,Down,0.0402396935595466,0.420077580347345
79,WP_FOXP3_IN_COVID19,9,Down,0.0403724195224334,0.420077580347345
80,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Down,0.0426576903541423,0.438307768388813
81,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.0432584147547841,0.438992801585587
82,WP_HIPPOYAP_SIGNALING,16,Down,0.0447239917157906,0.446995652316336
83,WP_ANGIOGENESIS,13,Down,0.0460076794020676,0.446995652316336
84,WP_HEART_DEVELOPMENT,16,Down,0.0461978691896679,0.446995652316336
85,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.0462221781592318,0.446995652316336
86,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.0482170296368985,0.455021598928479
87,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.0486928281486202,0.455021598928479
88,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.0487127745811511,0.455021598928479
89,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,135,Down,0.0494278784413224,0.456513663806371
90,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.0507009540061157,0.458208251148733
91,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0508231288105961,0.458208251148733
92,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.052509397800896,0.458208251148733
93,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.0526210494889374,0.458208251148733
94,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,6,Up,0.052751066251259,0.458208251148733
95,WP_NETRINUNC5B_SIGNALING,34,Down,0.0529559414344642,0.458208251148733
96,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.0562551569569655,0.475582565900249
97,WP_RETINOBLASTOMA_GENE_IN_CANCER,85,Down,0.0563920966464457,0.475582565900249
98,WP_13Q1212_COPY_NUMBER_VARIATION,19,Down,0.0579516386286044,0.475582565900249
99,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.0590569070239681,0.475582565900249
100,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.0594971566426402,0.475582565900249
101,WP_ONCOSTATIN_M_SIGNALING,54,Down,0.0596759232880747,0.475582565900249
102,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.0604977150448847,0.475582565900249
103,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.0606862721221546,0.475582565900249
104,WP_PLEURAL_MESOTHELIOMA,251,Down,0.0613129238094337,0.475582565900249
105,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.0619320791442669,0.475582565900249
106,WP_EFFECTS_OF_MFN2_MUTATION,17,Down,0.0622060697160027,0.475582565900249
107,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.0623978243682628,0.475582565900249
108,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,20,Up,0.0626955948141998,0.475582565900249
109,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,62,Down,0.0633868931288542,0.475582565900249
110,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0636424358260674,0.475582565900249
111,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.0666441612469297,0.487431853328606
112,WP_VITAMIN_D_RECEPTOR_PATHWAY,82,Down,0.0671322580412087,0.487431853328606
113,WP_EGFEGFR_SIGNALING,138,Down,0.0675668441114119,0.487431853328606
114,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.0676000380528723,0.487431853328606
115,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0691498283843469,0.488049536201034
116,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.0700385424916627,0.488049536201034
117,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,17,Down,0.0706679947253578,0.488049536201034
118,WP_IRON_METABOLISM_DISORDERS,12,Down,0.0707686682744101,0.488049536201034
119,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.0718753231386683,0.488049536201034
120,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,86,Down,0.0725310236420293,0.488049536201034
121,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,0.0729902933508276,0.488049536201034
122,WP_AXON_GUIDANCE,35,Down,0.0734840933610827,0.488049536201034
123,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.0737348929593671,0.488049536201034
124,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.0740901416609152,0.488049536201034
125,WP_CHEMOKINE_SIGNALING,105,Down,0.0746280318567878,0.488049536201034
126,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Down,0.0749232954886617,0.488049536201034
127,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.0754042470772888,0.488049536201034
128,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.0766751515591663,0.488799532968266
129,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.0767094157577936,0.488799532968266
130,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0775192746073283,0.490160336363261
131,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.0790386828307997,0.495952651045171
132,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.0804909821736236,0.499972224939526
133,WP_G13_SIGNALING,30,Down,0.080895749290702,0.499972224939526
134,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.0829918715622508,0.508749218937154
135,WP_NAD_METABOLISM,11,Down,0.0835537038400435,0.508749218937154
136,WP_WNT_SIGNALING_WP363,37,Down,0.0849938618364211,0.513712900217192
137,WP_PAFAH1B1_COPY_NUMBER_VARIATION,8,Down,0.0865130244391297,0.519078146634778
138,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,10,Down,0.0878819511627857,0.523470752578332
139,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0912153517533795,0.539417403894086
140,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Down,0.0929670284675307,0.544647852702771
141,WP_TNFALPHA_SIGNALING,83,Down,0.0941588047756774,0.544647852702771
142,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,4,Down,0.0946062994013722,0.544647852702771
143,WP_REGULATION_OF_ACTIN_CYTOSKELETON,91,Down,0.0947501738886815,0.544647852702771
144,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Down,0.100541667906941,0.565300006241504
145,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,27,Down,0.100626849137183,0.565300006241504
146,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.101336541677173,0.565300006241504
147,WP_NOTCH_SIGNALING_WP61,49,Down,0.101449436765763,0.565300006241504
148,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.101912340380796,0.565300006241504
149,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.103999601595354,0.565300006241504
150,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,8,Up,0.105227813973822,0.565300006241504
151,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,8,Up,0.105227813973822,0.565300006241504
152,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.105676216799503,0.565300006241504
153,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.10609993613641,0.565300006241504
154,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.106780589603392,0.565300006241504
155,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.107632280202003,0.565300006241504
156,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.107653370432273,0.565300006241504
157,WP_MAPK_SIGNALING,159,Down,0.108026736403261,0.565300006241504
158,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.108658638669292,0.565300006241504
159,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.111222679416736,0.568732595235351
160,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,31,Down,0.111456537822089,0.568732595235351
161,WP_MICROTUBULE_CYTOSKELETON_REGULATION,36,Down,0.112726448409605,0.568732595235351
162,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,9,Down,0.113074328052692,0.568732595235351
163,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.113966441249494,0.568732595235351
164,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,75,Down,0.114038885404337,0.568732595235351
165,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.114603774941125,0.568732595235351
166,WP_AMINO_ACID_METABOLISM,57,Up,0.115227784907229,0.568732595235351
167,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,45,Down,0.116267662700498,0.568732595235351
168,WP_NRXN1_DELETION_SYNDROME,2,Up,0.116646925168781,0.568732595235351
169,WP_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.117621096338211,0.568732595235351
170,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,24,Up,0.117621096338211,0.568732595235351
171,WP_DOPAMINE_METABOLISM,7,Up,0.119436194320336,0.571078498824562
172,WP_BREAST_CANCER_PATHWAY,88,Down,0.119559719346114,0.571078498824562
173,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.120190486978892,0.571078498824562
174,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.120885582071984,0.571080163581442
175,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Down,0.122181428801998,0.573903625572812
176,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.126349967056553,0.581493397756329
177,WP_GPCRS_OTHER,11,Down,0.12680492230362,0.581493397756329
178,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,5,Down,0.127069232884933,0.581493397756329
179,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Down,0.127266551898895,0.581493397756329
180,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.127589443802569,0.581493397756329
181,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.128419399346979,0.581493397756329
182,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,30,Down,0.128749146461864,0.581493397756329
183,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,65,Down,0.130280962636124,0.582979545686048
184,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.130707699421557,0.582979545686048
185,WP_FOCAL_ADHESION,114,Down,0.131676902466275,0.582979545686048
186,WP_ALLOGRAFT_REJECTION,49,Down,0.132334340225048,0.582979545686048
187,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.132624300539284,0.582979545686048
188,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.133475976127241,0.583168376317898
189,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.134761421220852,0.583168376317898
190,WP_PROLACTIN_SIGNALING,69,Down,0.134795610097811,0.583168376317898
191,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,40,Down,0.135651129703943,0.583797008464089
192,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,11,Down,0.139861629107932,0.593163059808491
193,WP_7OXOC_AND_7BETAHC_PATHWAYS,16,Down,0.140254151436654,0.593163059808491
194,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.14032539315661,0.593163059808491
195,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,50,Down,0.141039814476508,0.593163059808491
196,WP_ENDOTHELIN_PATHWAYS,12,Down,0.142508507855508,0.593163059808491
197,WP_METHYLATION_PATHWAYS,5,Up,0.143967832786098,0.593163059808491
198,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.143997144879426,0.593163059808491
199,WP_GPR40_PATHWAY,10,Up,0.14404969021363,0.593163059808491
200,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.144321912362163,0.593163059808491
201,WP_NEPHROGENESIS,4,Up,0.145544426425017,0.595211534932159
202,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,29,Down,0.147041923164325,0.597327090484836
203,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.148196877064781,0.597327090484836
204,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.148241759682368,0.597327090484836
205,WP_ARYLAMINE_METABOLISM,1,Up,0.149680057283826,0.599230647750392
206,WP_EBOLA_VIRUS_INFECTION_IN_HOST,108,Down,0.150172157465427,0.599230647750392
207,WP_TAMOXIFEN_METABOLISM,2,Up,0.150930807887099,0.599348425522682
208,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.153188210357859,0.605388023625769
209,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,62,Down,0.154096696018449,0.606064517354856
210,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.155276371514866,0.607444856972437
211,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.155925626303144,0.607444856972437
212,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.157356138019147,0.61012615779122
213,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.158266551049071,0.610775140668247
214,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Down,0.161111835783971,0.616910661712862
215,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.161357411518571,0.616910661712862
216,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.162690777330818,0.617521667701256
217,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,17,Down,0.163019710329894,0.617521667701256
218,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.166293366520916,0.625188976761181
219,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.16656494636338,0.625188976761181
220,WP_GENES_CONTROLLING_NEPHROGENESIS,12,Down,0.170889331279459,0.633550654736093
221,WP_WNT_SIGNALING_WP428,56,Down,0.171406554658483,0.633550654736093
222,WP_MAPK_CASCADE,30,Down,0.171801340270116,0.633550654736093
223,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.172278822947462,0.633550654736093
224,WP_HIPPO_SIGNALING_REGULATION,44,Down,0.173407410150806,0.633550654736093
225,WP_GASTRIC_CANCER_NETWORK_2,27,Down,0.173700284000846,0.633550654736093
226,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.17495863579695,0.633550654736093
227,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.17495863579695,0.633550654736093
228,WP_PDGF_PATHWAY,36,Down,0.176189338586887,0.633582348523978
229,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Down,0.176508951109478,0.633582348523978
230,WP_RANKLRANK_SIGNALING,48,Down,0.177777958945928,0.634486749870939
231,WP_ACUTE_VIRAL_MYOCARDITIS,63,Up,0.179534288710036,0.634486749870939
232,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,48,Down,0.179900809713543,0.634486749870939
233,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.181068557999864,0.634486749870939
234,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,22,Down,0.181302461555132,0.634486749870939
235,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.181392197347531,0.634486749870939
236,WP_SMALL_CELL_LUNG_CANCER,68,Down,0.18266501029219,0.636231518899069
237,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,30,Down,0.184088586734414,0.638484465382651
238,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.185928567430823,0.638767880135967
239,WP_VITAMIN_B12_METABOLISM,23,Down,0.186017452016192,0.638767880135967
240,WP_ECTODERM_DIFFERENTIATION,75,Down,0.187259396916016,0.638767880135967
241,WP_FATTY_ACID_BETAOXIDATION,28,Up,0.187278660721129,0.638767880135967
242,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.190459297155084,0.64693199281603
243,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.192809627976089,0.650591579953681
244,WP_CELL_DIFFERENTIATION_INDEX,6,Down,0.196610521537656,0.650591579953681
245,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.196641193113162,0.650591579953681
246,WP_MONOAMINE_TRANSPORT,12,Down,0.196738559062923,0.650591579953681
247,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.197354926452486,0.650591579953681
248,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,124,Down,0.198263769180458,0.650591579953681
249,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.198640340892877,0.650591579953681
250,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.198967864322565,0.650591579953681
251,WP_INTEGRINMEDIATED_CELL_ADHESION,71,Down,0.19915334821833,0.650591579953681
252,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,53,Up,0.200122984725853,0.650591579953681
253,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,63,Up,0.200242907212021,0.650591579953681
254,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.204302290929798,0.657267708231084
255,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.204803743804997,0.657267708231084
256,WP_PPAR_SIGNALING,38,Up,0.205616742990002,0.657267708231084
257,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.206721926280881,0.657267708231084
258,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.207027686077641,0.657267708231084
259,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,47,Down,0.207095299795439,0.657267708231084
260,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.209380318064886,0.661963928651292
261,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.212345987460871,0.668767822577916
262,WP_OSTEOBLAST_SIGNALING,2,Up,0.217106107193041,0.678972632238366
263,WP_AFLATOXIN_B1_METABOLISM,2,Down,0.217238202285511,0.678972632238366
264,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.219506950870499,0.683464824301326
265,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.226313876576522,0.702000024701513
266,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,61,Down,0.227232867224319,0.702200815257107
267,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,15,Down,0.231278746246802,0.708886777409344
268,WP_VALPROIC_ACID_PATHWAY,8,Up,0.231873212448199,0.708886777409344
269,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.231983629103544,0.708886777409344
270,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.23392777468794,0.709813863625635
271,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Down,0.234128069930938,0.709813863625635
272,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,8,Down,0.23499214017059,0.709813863625635
273,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.235741100693185,0.709813863625635
274,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.236731264859198,0.710193794577594
275,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.238763911196646,0.713687036376883
276,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Down,0.240120664992932,0.715141980522428
277,WP_DISORDERS_IN_KETOLYSIS,5,Down,0.242330573753559,0.719118164712727
278,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.24380459077419,0.72072543418285
279,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,29,Up,0.244820103317514,0.72072543418285
280,WP_MELANOMA,56,Down,0.246408369512325,0.72072543418285
281,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.247203367008567,0.72072543418285
282,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.247256170851051,0.72072543418285
283,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.24949901465514,0.72469325104779
284,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.254902733456574,0.736964892634642
285,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.255763501006032,0.736964892634642
286,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.256971445909667,0.736964892634642
287,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.257310126747132,0.736964892634642
288,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.259719017506895,0.739047142453611
289,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.259835309208143,0.739047142453611
290,WP_CIRCADIAN_RHYTHM_GENES,118,Down,0.260888719751128,0.739484578053199
291,WP_NEPHROTIC_SYNDROME,29,Down,0.263218988813408,0.739940414724006
292,WP_CELL_CYCLE,107,Down,0.264708969858368,0.739940414724006
293,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,15,Down,0.265015966792705,0.739940414724006
294,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.26538872961402,0.739940414724006
295,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Down,0.265550392145477,0.739940414724006
296,WP_BENZENE_METABOLISM,3,Up,0.267453690977158,0.740872135679794
297,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.268141040035843,0.740872135679794
298,WP_DRAVET_SYNDROME,12,Down,0.268797434590578,0.740872135679794
299,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.27028128291239,0.740872135679794
300,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,4,Up,0.271556779545509,0.740872135679794
301,WP_HOMOLOGOUS_RECOMBINATION,13,Down,0.271753505911384,0.740872135679794
302,WP_PYRIMIDINE_METABOLISM,74,Down,0.272193898996713,0.740872135679794
303,WP_SPHINGOLIPID_PATHWAY,20,Down,0.274204395420378,0.741467627945727
304,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Down,0.274216738315695,0.741467627945727
305,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.276195923602303,0.742291771096305
306,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,66,Down,0.276327593619792,0.742291771096305
307,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,81,Down,0.278161748646814,0.744521742368599
308,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,38,Up,0.278969217335193,0.744521742368599
309,WP_VEGFAVEGFR2_SIGNALING,342,Down,0.28099406370331,0.745274512350761
310,WP_TOLLLIKE_RECEPTOR_SIGNALING,78,Down,0.281064597115251,0.745274512350761
311,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,34,Down,0.283052455661311,0.748132213998706
312,WP_DNA_REPLICATION,41,Down,0.286738512918525,0.754001459051946
313,WP_INSULIN_SIGNALING,130,Down,0.287451000386081,0.754001459051946
314,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.288024888250987,0.754001459051946
315,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.291061662062817,0.758466163604139
316,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.292487691654675,0.758466163604139
317,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.29280448765458,0.758466163604139
318,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Down,0.293421216576784,0.758466163604139
319,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.294480750377576,0.758818736082657
320,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.296308092092397,0.761141411562345
321,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.299367852419812,0.764059197045888
322,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Down,0.301279422371715,0.764059197045888
323,WP_PRIMARY_OVARIAN_INSUFFICIENCY,96,Down,0.301674045548702,0.764059197045888
324,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.302372220698943,0.764059197045888
325,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.303683291870952,0.764059197045888
326,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.305384010922491,0.764059197045888
327,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.306112254381165,0.764059197045888
328,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.306697888798861,0.764059197045888
329,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.307311306113772,0.764059197045888
330,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,10,Down,0.307638297307744,0.764059197045888
331,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.307668606109719,0.764059197045888
332,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.309244001879487,0.764240327288629
333,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.309601008500138,0.764240327288629
334,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.310666364457397,0.764574106538863
335,WP_MIRNA_BIOGENESIS,6,Up,0.313630208811113,0.766866854505651
336,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.31375189398752,0.766866854505651
337,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.31439675178638,0.766866854505651
338,WP_PREIMPLANTATION_EMBRYO,21,Down,0.316976725930161,0.770302757113364
339,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,16,Down,0.318369917166363,0.770302757113364
340,WP_15Q11Q13_COPY_NUMBER_VARIATION,30,Up,0.318616712188009,0.770302757113364
341,WP_NPHP1_DELETION_SYNDROME,10,Down,0.320357730952659,0.772230816701064
342,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.323626022317004,0.772230816701064
343,WP_HISTONE_MODIFICATIONS,37,Up,0.325652556455277,0.772230816701064
344,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.325964590386227,0.772230816701064
345,WP_PPARALPHA_PATHWAY,15,Up,0.326120188672841,0.772230816701064
346,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.326577737712032,0.772230816701064
347,WP_CREATINE_PATHWAY,2,Up,0.327886283781089,0.772230816701064
348,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.328906252758652,0.772230816701064
349,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.331563857326477,0.772230816701064
350,WP_NUCLEOTIDE_GPCRS,5,Up,0.331671939696504,0.772230816701064
351,WP_G1_TO_S_CELL_CYCLE_CONTROL,57,Down,0.33186875863967,0.772230816701064
352,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,42,Down,0.332409928150719,0.772230816701064
353,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,34,Down,0.333078835061437,0.772230816701064
354,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,2,Down,0.333101352563397,0.772230816701064
355,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,89,Down,0.334117675085796,0.772230816701064
356,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,36,Down,0.334445463194135,0.772230816701064
357,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.335900362558473,0.77341764152119
358,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.33713377261856,0.774089276794572
359,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,11,Up,0.338820668760299,0.77579551454308
360,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Down,0.34184366670862,0.779093694069253
361,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,24,Up,0.342156719658151,0.779093694069253
362,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.345980357781193,0.785623906342929
363,WP_AEROBIC_GLYCOLYSIS,10,Up,0.353429695035898,0.79493920082747
364,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.353429695035898,0.79493920082747
365,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.355332226248086,0.79493920082747
366,WP_NAD_BIOSYNTHETIC_PATHWAYS,18,Down,0.355589672634129,0.79493920082747
367,WP_CILIARY_LANDSCAPE,185,Down,0.356387433448314,0.79493920082747
368,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.356752298437079,0.79493920082747
369,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Up,0.357249699231424,0.79493920082747
370,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Down,0.357819348304335,0.79493920082747
371,WP_IL18_SIGNALING,191,Down,0.360393824675785,0.795850715865531
372,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,17,Down,0.361005445302277,0.795850715865531
373,WP_OPIOID_RECEPTOR_PATHWAYS,25,Down,0.361134205617814,0.795850715865531
374,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.364113978056117,0.799395619423897
375,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,39,Up,0.365871402141693,0.799395619423897
376,WP_FOLATE_METABOLISM,36,Down,0.366568759582652,0.799395619423897
377,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.366632784091009,0.799395619423897
378,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,25,Down,0.372258654016321,0.809514850797395
379,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.377287544801225,0.81828591510978
380,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Down,0.38238033557533,0.827149041691899
381,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.386025092604369,0.83131767486408
382,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.386331068119289,0.83131767486408
383,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,5,Up,0.387341447047375,0.83131767486408
384,WP_HEPATITIS_B_INFECTION,116,Down,0.389873544823379,0.834573056887547
385,WP_LUNG_FIBROSIS,30,Down,0.39270628461951,0.837791255784816
386,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.393415358555887,0.837791255784816
387,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.394513663683718,0.837959254646036
388,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.397199681670929,0.841490047251298
389,WP_IRON_METABOLISM_IN_PLACENTA,9,Down,0.404396682672395,0.847201391247071
390,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.404537852709766,0.847201391247071
391,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,48,Down,0.404863833076432,0.847201391247071
392,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,24,Down,0.408398336700691,0.847201391247071
393,WP_16P112_DISTAL_DELETION_SYNDROME,21,Up,0.409123799440221,0.847201391247071
394,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Down,0.409837386781381,0.847201391247071
395,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Down,0.410171897815474,0.847201391247071
396,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,10,Down,0.410894694182314,0.847201391247071
397,WP_BLADDER_CANCER,29,Down,0.411793767665576,0.847201391247071
398,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.415227975440018,0.847201391247071
399,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.416874528727639,0.847201391247071
400,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.417143781518097,0.847201391247071
401,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,17,Down,0.417798012576037,0.847201391247071
402,WP_MACROPHAGE_MARKERS,8,Up,0.418019159282646,0.847201391247071
403,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.418534161523803,0.847201391247071
404,WP_HEME_BIOSYNTHESIS,8,Down,0.418534161523803,0.847201391247071
405,WP_CANCER_PATHWAYS,300,Down,0.418669994421548,0.847201391247071
406,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.41925019977311,0.847201391247071
407,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.419478061116251,0.847201391247071
408,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Down,0.42405500993855,0.854346122964431
409,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.425450114409641,0.855061110133802
410,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Down,0.430232700924617,0.858954851053723
411,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.431445708409847,0.858954851053723
412,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Up,0.43146396128512,0.858954851053723
413,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.432069150205207,0.858954851053723
414,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.433143677048166,0.858954851053723
415,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.433657254485761,0.858954851053723
416,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.435044050655619,0.859630311632017
417,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.438557373456701,0.864151640065364
418,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.439434775605015,0.864151640065364
419,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.441514176179103,0.866168622480244
420,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.447626259162605,0.870741099066613
421,WP_MEASLES_VIRUS_INFECTION,101,Up,0.448385904743641,0.870741099066613
422,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.448721103395936,0.870741099066613
423,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,0.449014010323619,0.870741099066613
424,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.449141394165747,0.870741099066613
425,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.455306212375466,0.879018749047031
426,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.455549862644812,0.879018749047031
427,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.456733770559251,0.879239249179636
428,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.460722583306145,0.883054906652401
429,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,19,Down,0.460864422085012,0.883054906652401
430,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,2,Up,0.462832603708268,0.884763721507434
431,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.466919761192389,0.885489987030769
432,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.467786207128712,0.885489987030769
433,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,14,Down,0.469059245791225,0.885489987030769
434,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.469355732304071,0.885489987030769
435,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.469717012941112,0.885489987030769
436,WP_ALZHEIMERS_DISEASE,184,Down,0.471334248283087,0.885489987030769
437,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Down,0.471334248283087,0.885489987030769
438,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Down,0.473466373788435,0.885489987030769
439,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.474409846695704,0.885489987030769
440,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.474491205303579,0.885489987030769
441,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.475062146326727,0.885489987030769
442,WP_CYTOSINE_METHYLATION,7,Down,0.477603137363087,0.887049161345393
443,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.478056908121666,0.887049161345393
444,WP_ERBB_SIGNALING,68,Down,0.482908661112705,0.892658277957323
445,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Up,0.484616517724044,0.892658277957323
446,WP_GLUTATHIONE_METABOLISM,10,Down,0.484891797471979,0.892658277957323
447,WP_IL17_SIGNALING,25,Up,0.486542397863061,0.892658277957323
448,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.487299528610932,0.892658277957323
449,WP_NEURAL_CREST_DIFFERENTIATION,38,Down,0.488244690832804,0.892658277957323
450,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.48882201163711,0.892658277957323
451,WP_ETHER_LIPID_BIOSYNTHESIS,15,Up,0.489767498003349,0.892658277957323
452,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.492556188374744,0.895324371212996
453,WP_ENDOMETRIAL_CANCER,49,Down,0.49340868632541,0.895324371212996
454,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.497230974550741,0.89540161538927
455,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.497430173579962,0.89540161538927
456,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,75,Down,0.498619091009428,0.89540161538927
457,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.49980642029643,0.89540161538927
458,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.500297148042955,0.89540161538927
459,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.500872577479224,0.89540161538927
460,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,9,Down,0.501466803231687,0.89540161538927
461,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.502192051726073,0.89540161538927
462,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.503254922518057,0.89540161538927
463,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.506868548023936,0.89946086435283
464,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.507724867469238,0.89946086435283
465,WP_G_PROTEIN_SIGNALING,61,Down,0.511513175299476,0.901218215266054
466,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.512179939215312,0.901218215266054
467,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.514281136785415,0.901218215266054
468,WP_ENDOCHONDRAL_OSSIFICATION,27,Down,0.51428466215732,0.901218215266054
469,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,27,Down,0.51428466215732,0.901218215266054
470,WP_COMPLEMENT_SYSTEM,51,Up,0.515295086587647,0.901218215266054
471,WP_ATM_SIGNALING,37,Down,0.516922674437563,0.901382364170527
472,WP_DNA_DAMAGE_RESPONSE,63,Down,0.517582087455583,0.901382364170527
473,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.519275778359932,0.902420063027198
474,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.525775540060555,0.903257838653587
475,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.533795118713962,0.903257838653587
476,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.534490305986615,0.903257838653587
477,WP_APOPTOSIS,71,Down,0.535281634807832,0.903257838653587
478,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.53605986412327,0.903257838653587
479,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,2,Down,0.536183587254683,0.903257838653587
480,WP_TCA_CYCLE_IN_SENESCENCE,9,Down,0.536716853704365,0.903257838653587
481,WP_TYPE_II_INTERFERON_SIGNALING,29,Down,0.537705835954391,0.903257838653587
482,WP_PROTEASOME_DEGRADATION,57,Down,0.53797113708967,0.903257838653587
483,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,8,Down,0.539916946321061,0.903257838653587
484,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.541140713946585,0.903257838653587
485,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.541433384520456,0.903257838653587
486,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.543586375632481,0.903257838653587
487,WP_SPINA_BIFIDA,10,Up,0.544093028997452,0.903257838653587
488,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,16,Down,0.544369664647212,0.903257838653587
489,WP_PRION_DISEASE_PATHWAY,28,Down,0.546103914072778,0.903257838653587
490,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,75,Down,0.547122530969974,0.903257838653587
491,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.548755955104955,0.903257838653587
492,WP_DNA_MISMATCH_REPAIR,23,Down,0.548923953989813,0.903257838653587
493,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.549496378018075,0.903257838653587
494,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.550296381194453,0.903257838653587
495,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.55205657811297,0.903257838653587
496,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,24,Down,0.552407259952749,0.903257838653587
497,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,3,Down,0.55253449045842,0.903257838653587
498,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Down,0.554288090976728,0.903257838653587
499,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.554449245495036,0.903257838653587
500,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,45,Down,0.555061507841739,0.903257838653587
501,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.555513483847533,0.903257838653587
502,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,10,Up,0.556842279085479,0.903257838653587
503,WP_OSTEOCLAST_SIGNALING,8,Down,0.557337642694619,0.903257838653587
504,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.558681351714374,0.903257838653587
505,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,40,Down,0.558781684406934,0.903257838653587
506,WP_CELLULAR_PROTEOSTASIS,6,Down,0.561693790801336,0.903257838653587
507,WP_AUTOPHAGY,27,Down,0.561801011063214,0.903257838653587
508,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,49,Up,0.5635277887486,0.903257838653587
509,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.564347334044311,0.903257838653587
510,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.56542814196082,0.903257838653587
511,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.566356179871889,0.903257838653587
512,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.567224070378636,0.903257838653587
513,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,12,Up,0.568944160270615,0.903257838653587
514,WP_NUCLEOTIDE_EXCISION_REPAIR,44,Down,0.569347608236978,0.903257838653587
515,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.569883481064375,0.903257838653587
516,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,11,Down,0.570205680168142,0.903257838653587
517,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.571452461512501,0.903257838653587
518,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.571760034758637,0.903257838653587
519,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.572408251845455,0.903257838653587
520,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.573914505732211,0.903257838653587
521,WP_PHOSPHOINOSITIDES_METABOLISM,39,Up,0.573955491529813,0.903257838653587
522,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.575047033189194,0.903257838653587
523,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,23,Up,0.575124994300559,0.903257838653587
524,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,12,Down,0.575799400796204,0.903257838653587
525,WP_RAS_SIGNALING,115,Up,0.578229480831878,0.905342158559626
526,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.58175747238717,0.907914472870102
527,WP_ESTROGEN_SIGNALING,21,Down,0.582081419954433,0.907914472870102
528,WP_RETINOL_METABOLISM,6,Up,0.584233947989387,0.908923673277844
529,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.584939930856423,0.908923673277844
530,WP_GLYCOLYSIS_IN_SENESCENCE,10,Down,0.592256961485066,0.916240562045139
531,WP_VITAMIN_B12_DISORDERS,9,Down,0.592446666065725,0.916240562045139
532,WP_MATRIX_METALLOPROTEINASES,8,Up,0.593503319143246,0.916240562045139
533,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.594773085757248,0.916240562045139
534,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.595221970963631,0.916240562045139
535,WP_15Q25_COPY_NUMBER_VARIATION,27,Down,0.596550655015907,0.916569417613226
536,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,47,Up,0.60076997822622,0.916632097024776
537,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,24,Down,0.601123202361196,0.916632097024776
538,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,28,Up,0.602397171002916,0.916632097024776
539,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.603576777882094,0.916632097024776
540,WP_UROTENSINIIMEDIATED_SIGNALING,50,Down,0.604610236626393,0.916632097024776
541,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,7,Up,0.60567911812543,0.916632097024776
542,WP_EICOSANOID_SYNTHESIS,14,Down,0.6067660225966,0.916632097024776
543,WP_GLUCURONIDATION,7,Down,0.607196943582682,0.916632097024776
544,WP_NRF2ARE_REGULATION,20,Up,0.608497603288403,0.916632097024776
545,WP_IL19_SIGNALING,20,Down,0.609024272717403,0.916632097024776
546,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.610588347444225,0.916632097024776
547,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,34,Down,0.610735133707344,0.916632097024776
548,WP_VITAMIN_D_METABOLISM,6,Up,0.61164216669499,0.916632097024776
549,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.61220318888881,0.916632097024776
550,WP_ID_SIGNALING,12,Down,0.614368930205129,0.91721994715027
551,WP_TP53_NETWORK,16,Up,0.617741561165114,0.91721994715027
552,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.617903424618108,0.91721994715027
553,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.617910305138863,0.91721994715027
554,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.621054092470615,0.91721994715027
555,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,28,Down,0.621137455861912,0.91721994715027
556,WP_FERROPTOSIS,50,Down,0.623813289762676,0.91721994715027
557,WP_THERMOGENESIS,73,Down,0.62407703491588,0.91721994715027
558,WP_NUCLEAR_RECEPTORS_METAPATHWAY,171,Down,0.625082219666613,0.91721994715027
559,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.626175337703871,0.91721994715027
560,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.627186289534891,0.91721994715027
561,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.628102115052354,0.91721994715027
562,WP_ATR_SIGNALING,10,Down,0.628962227914942,0.91721994715027
563,WP_NONHOMOLOGOUS_END_JOINING,10,Up,0.629173165860194,0.91721994715027
564,WP_LEPTIN_AND_ADIPONECTIN,8,Down,0.629423056299601,0.91721994715027
565,WP_MRNA_PROCESSING,124,Down,0.630515853601906,0.91721994715027
566,WP_MITOCHONDRIAL_GENE_EXPRESSION,17,Down,0.631565073098604,0.91721994715027
567,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,53,Down,0.636212895194267,0.922340387741954
568,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,42,Up,0.641031384988352,0.925045864488509
569,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,79,Down,0.642428499247411,0.925045864488509
570,WP_P38_MAPK_SIGNALING,31,Down,0.643458521914207,0.925045864488509
571,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.644099496084753,0.925045864488509
572,WP_ENERGY_METABOLISM,40,Down,0.644667676676437,0.925045864488509
573,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.645197710847568,0.925045864488509
574,WP_MONOAMINE_GPCRS,3,Down,0.647120918055757,0.925045864488509
575,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.648043102495342,0.925045864488509
576,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,44,Down,0.648207321101437,0.925045864488509
577,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.65248648692877,0.926360829280459
578,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,69,Down,0.653681796498261,0.926360829280459
579,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.654011624133106,0.926360829280459
580,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,14,Up,0.655399866455796,0.926360829280459
581,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Down,0.656077983839459,0.926360829280459
582,WP_KIT_RECEPTOR_SIGNALING,52,Up,0.657659508268582,0.926360829280459
583,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.65801354197828,0.926360829280459
584,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.65814443345473,0.926360829280459
585,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.659971522691879,0.926863831899901
586,WP_PURINE_METABOLISM,10,Down,0.661510011778166,0.926863831899901
587,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,64,Down,0.662418971579219,0.926863831899901
588,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.663175491616376,0.926863831899901
589,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,163,Up,0.664784838298355,0.926863831899901
590,WP_10Q22Q23_COPY_NUMBER_VARIATION,28,Up,0.665267227276085,0.926863831899901
591,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.666818113597786,0.92732932700868
592,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,16,Up,0.667864318513285,0.92732932700868
593,WP_SILDENAFIL_TREATMENT,11,Up,0.668985755372442,0.92732932700868
594,WP_GASTRIC_CANCER_NETWORK_1,21,Down,0.675094615644029,0.930676405861735
595,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.675294499535529,0.930676405861735
596,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.675825749364695,0.930676405861735
597,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.676791704771128,0.930676405861735
598,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.679977206958682,0.930676405861735
599,WP_ENDODERM_DIFFERENTIATION,80,Up,0.680559877621739,0.930676405861735
600,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,67,Down,0.681475057417209,0.930676405861735
601,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.681515607784446,0.930676405861735
602,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.681921450515229,0.930676405861735
603,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.68286548010277,0.930676405861735
604,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.683854682652661,0.930676405861735
605,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.687400340145887,0.933489586214899
606,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.688607154148145,0.933489586214899
607,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.689634577011515,0.933489586214899
608,WP_KININKALLIKREIN_PATHWAY,2,Down,0.693252240248717,0.933489586214899
609,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.693829640033316,0.933489586214899
610,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.694350520798677,0.933489586214899
611,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.694451614236558,0.933489586214899
612,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,88,Down,0.695006845211093,0.933489586214899
613,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,58,Down,0.70428494622039,0.942992743676439
614,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.70437657496026,0.942992743676439
615,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Down,0.705773045569216,0.943325924321782
616,WP_APOPTOSIS_MODULATION_AND_SIGNALING,76,Up,0.708087426783176,0.944844065438603
617,WP_LEPTIN_SIGNALING,70,Down,0.709207771746494,0.944844065438603
618,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.713041133179238,0.946805980504016
619,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.713932964910606,0.946805980504016
620,WP_GLIAL_CELL_DIFFERENTIATION,4,Up,0.714135897703759,0.946805980504016
621,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.716303086370875,0.947640494187539
622,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Up,0.717071030881569,0.947640494187539
623,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.720847739745674,0.95110247523426
624,WP_IL2_SIGNALING,36,Up,0.723271389459879,0.951472660885341
625,WP_IL9_SIGNALING,14,Up,0.723443324882407,0.951472660885341
626,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,7,Down,0.729813208628451,0.956196026480597
627,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,25,Down,0.732139325938243,0.956196026480597
628,WP_ACUTE_MYELOID_LEUKEMIA,56,Up,0.732375639184321,0.956196026480597
629,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,38,Down,0.733646504993569,0.956196026480597
630,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,21,Down,0.735992096199874,0.956196026480597
631,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.736439448035391,0.956196026480597
632,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.738363247986715,0.956196026480597
633,WP_HUNGER_AND_SATIETY,2,Up,0.738610688969343,0.956196026480597
634,WP_BARDETBIEDL_SYNDROME,64,Down,0.738676789786557,0.956196026480597
635,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.739057196367737,0.956196026480597
636,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.741664223345815,0.956196026480597
637,WP_MALE_INFERTILITY,70,Up,0.741720854070118,0.956196026480597
638,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.742291832737802,0.956196026480597
639,WP_BDNFTRKB_SIGNALING,27,Down,0.74390647729086,0.956196026480597
640,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.744483524267132,0.956196026480597
641,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.747310920232016,0.958330072434816
642,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.749692868486797,0.958541687012865
643,WP_TCELL_RECEPTOR_SIGNALING,72,Down,0.749808156629285,0.958541687012865
644,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.752630496040262,0.960655695256359
645,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.759452827869873,0.967806120551701
646,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.762525078921978,0.967806120551701
647,WP_4P163_COPY_NUMBER_VARIATION,22,Up,0.764274446524431,0.967806120551701
648,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,12,Down,0.765229640678729,0.967806120551701
649,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Down,0.765394377471733,0.967806120551701
650,WP_SLEEP_REGULATION,10,Up,0.765585628749411,0.967806120551701
651,WP_ALSTROM_SYNDROME,26,Down,0.767338310478899,0.967806120551701
652,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Up,0.769602741547726,0.967806120551701
653,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,39,Down,0.769929695447622,0.967806120551701
654,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.77000632949004,0.967806120551701
655,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,20,Up,0.776043139114562,0.973904519621634
656,WP_IDO_METABOLIC_PATHWAY,6,Down,0.778448540405109,0.97419761760655
657,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.779595033592688,0.97419761760655
658,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.78100336815568,0.97419761760655
659,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.781738211545317,0.97419761760655
660,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,17,Up,0.78220246669139,0.97419761760655
661,WP_NUCLEAR_RECEPTORS,20,Up,0.78612259804473,0.977598752787849
662,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,84,Down,0.789969331110418,0.98006612754945
663,WP_BASE_EXCISION_REPAIR,31,Down,0.792026048760834,0.98006612754945
664,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.792862499695488,0.98006612754945
665,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.794512733989794,0.98006612754945
666,WP_PI3KAKT_SIGNALING,175,Up,0.795971269514887,0.98006612754945
667,WP_JOUBERT_SYNDROME,70,Up,0.796703532388538,0.98006612754945
668,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.797922181852481,0.98006612754945
669,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.798418345869624,0.98006612754945
670,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,21,Down,0.801020797236357,0.98006612754945
671,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.801935234056123,0.98006612754945
672,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.803218684072686,0.98006612754945
673,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.803467671087651,0.98006612754945
674,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.804783314794988,0.98006612754945
675,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.804798827367249,0.98006612754945
676,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Down,0.806680591785041,0.980635243806711
677,WP_IL5_SIGNALING,37,Up,0.809218483394404,0.980635243806711
678,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.809445765935148,0.980635243806711
679,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.810888588420838,0.980635243806711
680,WP_PDGFRBETA_PATHWAY,28,Down,0.811231101932559,0.980635243806711
681,WP_ACE_INHIBITOR_PATHWAY,4,Down,0.813557929146558,0.980739162466442
682,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.8137032953797,0.980739162466442
683,WP_ADIPOGENESIS,83,Up,0.817673274559497,0.981847984861149
684,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.817764164939567,0.981847984861149
685,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.818787858068232,0.981847984861149
686,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,11,Down,0.820246741390206,0.981847984861149
687,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.820595578588333,0.981847984861149
688,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.822318134355949,0.982478933779927
689,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,13,Up,0.823819796286031,0.982844517484931
690,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.825845820826764,0.9833175612996
691,WP_STEROID_BIOSYNTHESIS,2,Up,0.829153953706167,0.9833175612996
692,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.829350634591941,0.9833175612996
693,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.829350634591941,0.9833175612996
694,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.830197551754163,0.9833175612996
695,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.832903349391557,0.983707280104444
696,WP_TGFB_SMAD_SIGNALING,7,Down,0.834346354634001,0.983707280104444
697,WP_KLEEFSTRA_SYNDROME,24,Up,0.834882708462228,0.983707280104444
698,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.835586214126105,0.983707280104444
699,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.840639374835481,0.983707280104444
700,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Down,0.84215453369277,0.983707280104444
701,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.84423635736671,0.983707280104444
702,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Up,0.844462149292487,0.983707280104444
703,WP_IL7_SIGNALING,22,Down,0.844464628159453,0.983707280104444
704,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.844544643308684,0.983707280104444
705,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Up,0.844680093992865,0.983707280104444
706,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.845875720491321,0.983707280104444
707,WP_BLOOD_CLOTTING_CASCADE,6,Down,0.849300020510413,0.983707280104444
708,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,12,Down,0.849766357195408,0.983707280104444
709,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,53,Up,0.850617407859418,0.983707280104444
710,WP_ZINC_HOMEOSTASIS,23,Up,0.855208874600428,0.983707280104444
711,WP_NOTCH_SIGNALING_WP268,35,Down,0.855944619770854,0.983707280104444
712,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.856260096878441,0.983707280104444
713,WP_OVARIAN_INFERTILITY,23,Down,0.859336732058851,0.983707280104444
714,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.860215988565261,0.983707280104444
715,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.861884204949637,0.983707280104444
716,WP_ALPHA_6_BETA_4_SIGNALING,24,Down,0.862376835577418,0.983707280104444
717,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.863260181321037,0.983707280104444
718,WP_NANOMATERIAL_INDUCED_APOPTOSIS,17,Up,0.863363425947112,0.983707280104444
719,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.863924553152285,0.983707280104444
720,WP_GLYOXYLATE_METABOLISM,5,Up,0.865026868387607,0.983707280104444
721,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.866020730393574,0.983707280104444
722,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.867036425484005,0.983707280104444
723,WP_PURINERGIC_SIGNALING,14,Down,0.867196654961905,0.983707280104444
724,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.867495507011149,0.983707280104444
725,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.868785132720719,0.983707280104444
726,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Up,0.868821758340421,0.983707280104444
727,WP_OSTEOPONTIN_SIGNALING,11,Down,0.872885524249303,0.986876975094399
728,WP_16P112_PROXIMAL_DELETION_SYNDROME,60,Up,0.874409072619217,0.986876975094399
729,WP_IL11_SIGNALING,41,Up,0.875223010758901,0.986876975094399
730,WP_SMALL_LIGAND_GPCRS,7,Down,0.876809666465375,0.987311706622655
731,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.881933181930926,0.991722401569386
732,WP_KALLMANN_SYNDROME,11,Up,0.88517579074652,0.993229612479109
733,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.885690153220422,0.993229612479109
734,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.888120049448648,0.994597657556932
735,WP_KREBS_CYCLE_DISORDERS,11,Up,0.891980594817039,0.997451646179975
736,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Down,0.893942922525539,0.997451646179975
737,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Up,0.896368682702038,0.997451646179975
738,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,45,Up,0.897400680567726,0.997451646179975
739,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,26,Up,0.899270366121996,0.997451646179975
740,WP_FOXA2_PATHWAY,9,Up,0.899574721946148,0.997451646179975
741,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.901523171751826,0.997451646179975
742,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Down,0.908029736844656,0.997451646179975
743,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.908480149824647,0.997451646179975
744,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,52,Up,0.910130282223983,0.997451646179975
745,WP_NRF2_PATHWAY,66,Up,0.910568133592835,0.997451646179975
746,WP_TRANSSULFURATION_PATHWAY,8,Up,0.912383721227187,0.997451646179975
747,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.912724684444362,0.997451646179975
748,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.912792167074181,0.997451646179975
749,WP_WNT_SIGNALING_AND_PLURIPOTENCY,58,Up,0.915179217745761,0.997451646179975
750,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.91564559666084,0.997451646179975
751,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.918886677531944,0.997451646179975
752,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Down,0.91995058597579,0.997451646179975
753,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,20,Down,0.920786602827606,0.997451646179975
754,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.922905723261171,0.997451646179975
755,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,34,Down,0.924561800566782,0.997451646179975
756,WP_CORI_CYCLE,11,Down,0.924770441073633,0.997451646179975
757,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.928671194719278,0.997451646179975
758,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Up,0.929005188268831,0.997451646179975
759,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.929152289790658,0.997451646179975
760,WP_MTHFR_DEFICIENCY,18,Up,0.92980057957516,0.997451646179975
761,WP_CAMKK2_PATHWAY,29,Up,0.930364065209659,0.997451646179975
762,WP_IL3_SIGNALING,46,Down,0.930944888245173,0.997451646179975
763,WP_TAR_SYNDROME,44,Up,0.932288070885327,0.997451646179975
764,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.934283000936862,0.997451646179975
765,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.935864767256971,0.997451646179975
766,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.9374320404913,0.997451646179975
767,WP_TCELL_ACTIVATION_SARSCOV2,62,Down,0.937778798941958,0.997451646179975
768,WP_FRAGILE_X_SYNDROME,83,Down,0.940537462531065,0.997451646179975
769,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.941344871396327,0.997451646179975
770,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.941518674187592,0.997451646179975
771,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.941910886887166,0.997451646179975
772,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.942702920109416,0.997451646179975
773,WP_IL6_SIGNALING,39,Down,0.944329579950503,0.997451646179975
774,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,119,Down,0.94434141546037,0.997451646179975
775,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.946366226866914,0.997451646179975
776,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.947320721632628,0.997451646179975
777,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Down,0.948042926318123,0.997451646179975
778,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Down,0.949631644352082,0.997451646179975
779,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,267,Up,0.950046045668109,0.997451646179975
780,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.950275248623566,0.997451646179975
781,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.951004897901589,0.997451646179975
782,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.951076114992969,0.997451646179975
783,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.951312884785769,0.997451646179975
784,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.951340742828589,0.997451646179975
785,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.953803249118601,0.997955461573521
786,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,171,Down,0.955250811067193,0.997955461573521
787,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.955463440703602,0.997955461573521
788,WP_CILIOPATHIES,126,Down,0.957877062381805,0.998990772627353
789,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Down,0.964138093153987,0.998990772627353
790,WP_FLUOROPYRIMIDINE_ACTIVITY,27,Down,0.964350393725649,0.998990772627353
791,WP_TRANSLATION_FACTORS,49,Up,0.965165882576972,0.998990772627353
792,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.965709219921303,0.998990772627353
793,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Up,0.966404294840308,0.998990772627353
794,WP_MESODERMAL_COMMITMENT_PATHWAY,75,Down,0.967107471608716,0.998990772627353
795,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.967210066246522,0.998990772627353
796,WP_RETT_SYNDROME,31,Up,0.968783995783955,0.998990772627353
797,WP_IL4_SIGNALING,50,Up,0.971731361432596,0.998990772627353
798,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,9,Down,0.972630682946144,0.998990772627353
799,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,10,Up,0.973437535830462,0.998990772627353
800,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,12,Up,0.975709837555736,0.998990772627353
801,WP_TRYPTOPHAN_METABOLISM,17,Down,0.976159800452484,0.998990772627353
802,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,7,Up,0.976829682467125,0.998990772627353
803,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.977048697060084,0.998990772627353
804,WP_GLIOBLASTOMA_SIGNALING,68,Up,0.978348589920559,0.998990772627353
805,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,56,Down,0.978461141416851,0.998990772627353
806,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.980895226813576,0.998990772627353
807,WP_ONECARBON_METABOLISM,23,Down,0.981661496824422,0.998990772627353
808,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,14,Down,0.981976331244405,0.998990772627353
809,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,52,Up,0.983779938665861,0.999018755135932
810,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,43,Down,0.98722761209671,0.999018755135932
811,WP_COPPER_HOMEOSTASIS,40,Down,0.988922061573889,0.999018755135932
812,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.989892868334552,0.999018755135932
813,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.990472729873722,0.999018755135932
814,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.9908620694594,0.999018755135932
815,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.992675310729427,0.999018755135932
816,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.993000839836182,0.999018755135932
817,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.993966307868017,0.999018755135932
818,WP_SERINE_METABOLISM,8,Up,0.994157350001451,0.999018755135932
819,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.997016362829369,0.999443849428913
820,WP_CHOLESTASIS,9,Down,0.99746466101309,0.999443849428913
821,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.998404079455996,0.999443849428913
822,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.999443849428913,0.999443849428913
